explore -WSS

explore

author：leisure time 2025-09-30 16:24:03 - browse：4

Rachel Haurwitz of Caribou Biosciences — Rachel Haurwitz, CEO of Caribou Biosciences. Elizabeth D. Herman for STAT

Caribou Biosciences said Thursday that its off-the-shelf CAR-T therapy induced durable, complete remissions in patients with advanced B-cell lymphoma that move it closer to the benchmarks set by more established, patient-specific CAR-T therapies.

In an update to an early-stage study, 44% of the 16 patients treated with Caribou’s on-demand therapy, called CB-010, achieved a complete remission lasting a minimum of six months — a key threshold of durability.

The CB-010 result is still preliminary, but it begins to compare favorably to currently approved CAR-T therapies, which must be custom made for each patient and have shown durable remission rates in the range of 36-40%, said Caribou CEO Rachel Haurwitz.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： BIO: Crackdown on China pharma industry would threaten U.S. drug supply

WSS

After Optum profits sink, UnitedHealth makes changes

Mark Cuban is blaming the wrong people for high drug costs

Why rehabilitation engineers need to center patients in their research

Hospitals are dialing back on venture capital investing

Bird flu researchers hone in on Finland’s mink farms

What to know about the judge who will handle the Trump case

hotspot

explore

entertainment

After affirmative action ruling, medical educators look to 'holistic review'

UnitedHealth financials solid despite Change Healthcare cyberattack

Cancer drug shortages should be causing more outrage

Diversity in clinical trials starts with building trust, experts say

Supreme Court strikes down use of affirmative action

Diversity in clinical trials starts with building trust, experts say

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Bird flu in milk supply is likely coming from asymptomatic cows

Sports medicine is finally prioritizing gender equality

Diversity in clinical trials starts with building trust, experts say

explore

Biogen’s boardroom scandal saddles CEO with first crisis

Why rehabilitation engineers need to center patients in their research

Aspartame and sugar

Dozens dead from Maui wildfires: What we know about the victims

Judge sides with young activists in first

Schizophrenia gene found to be linked to cells' energy dysfunction

leisure time

focus

hotspot

entertainment